Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Jonathan Cunningham, MD
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
FINE-HEART Pooled Analysis
Maria Pabon
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
Akshay S. Desai, MD
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
John Ostrominski
NYHA FC and Finerenone Response: Clinical Trial Insights
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Gautam Nayak, MD
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Michelle Kittleson, MD, PhD
Patient Case Study: Obesity and VTE
Renato D. Lopes, MD, MHS, PhD
Alexander T. Cohen, MD, MBBS
Patient Case Study: Elderly
Valeria Caso, MD, PhD
Don't Miss It! Rapid & Accurate AAV Diagnosis
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
Patient Case Study: Obesity
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.